 |
The Journal of Neuroscience, October 15, 2003, 23(28):9459-9468
Previous Article | Next Article 
Cellular/Molecular
Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats
Rita M. Cowell,1,3
Jennifer M. Plane,2 and
Faye S. Silverstein1,2,3
Departments of 1Neurology and 2Pediatrics, and 3Neuroscience Program, University of Michigan, Ann Arbor, Michigan 48109
Conflicting data have emerged regarding the role of complement activation in the pathophysiology of cerebral ischemia. On the basis of considerable evidence implicating inflammatory mediators in the progression of neonatal brain injury, we evaluated the contribution of complement activation to cerebral hypoxic-ischemic (HI) injury in the neonatal rat. To elicit unilateral forebrain HI injury, 7-d-old rats underwent right carotid ligation followed by 1.5-2 hr of exposure to 8% oxygen. Using immunoprecipitation and Western blot assays, we determined that HI induces local complement cascade activation as early as 8 hr post-HI; there was an eightfold increase in the activation fragment inactivated C3b at 16 hr. With immunofluorescence assays and confocal microscopy, both C3 and C9 were localized to injured neurons 16 and 24 hr post-HI. To investigate the contribution of systemic complement to brain injury, we administered the complement-depleting agent cobra venom factor (CVF) 24 hr before HI lesioning and evaluated both acute HI-induced complement deposition and the extent of resulting tissue injury 5 d after lesioning. CVF depleted both systemic and brain C3 by the time of surgery and reduced infarct size. Analysis of lesioned, CVF-treated animals demonstrated minimal neuronal C3 deposition but no reduction in C9 deposition. C3-immunoreactive microglia were identified in injured areas. These results indicate that complement activation contributes to HI injury in neonatal rat brain, systemic administration of CVF does not eliminate complement deposition within injured brain, and microglia may represent an important local source of C3 after acute brain injury.
Key words: microglia; endothelium; cobra venom factor; neonatal rat; stroke; C3
Received July 7, 2003;
revised September 3, 2003;
accepted September 4, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Dimayuga, F. H. Y. Cesena, K.-Y. Chyu, J. Yano, A. Amorn, M. C. Fishbein, P. K. Shah, and B. Cercek
Natural antibodies and complement modulate intimal thickening after arterial injury
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2009;
297(5):
R1593 - R1600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Lister and M. J. Hickey
Immune complexes alter cerebral microvessel permeability: roles of complement and leukocyte adhesion
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H694 - H704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Mocco, W. J. Mack, A. F. Ducruet, S. A. Sosunov, M. E. Sughrue, B. G. Hassid, M. N. Nair, I. Laufer, R. J. Komotar, M. Claire, et al.
Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia
Circ. Res.,
July 21, 2006;
99(2):
209 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Back, A. Riddle, and A. R. Hohimer
Topical Review: Role of Instrumented Fetal Sheep Preparations in Defining the Pathogenesis of Human Periventricular White-Matter Injury
J Child Neurol,
July 1, 2006;
21(7):
582 - 589.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Ten, S. A. Sosunov, S. P. Mazer, R. I. Stark, C. Caspersen, M. E. Sughrue, M. Botto, E. S. Connolly Jr, and D. J. Pinsky
C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice
Stroke,
October 1, 2005;
36(10):
2244 - 2250.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|